Literature DB >> 30704346

CRISPR/Cas9 Edited Induced Pluripotent Stem Cell-Based Vascular Tissues to Model Aging and Disease-Dependent Impairment.

Aylin Acun1, Pinar Zorlutuna1,2.   

Abstract

IMPACT STATEMENT: Modeling human disease as precisely as possible is of upmost importance in understanding the underlying pathology and discovering effective therapies. Therefore, disease models that are highly controlled and composed of human-origin cells that present the disease phenotype are crucial. The human induced pluripotent stem cell (hiPSC)-based tissue model we present in this study is an important example of human-origin tissue model with controlled gene expression. Through CRISPR/Cas9 editing of hypoxia inducible factor 1α in hiPSCs, we developed tissue models that show the age and disease-dependent endothelial deterioration. This model holds promise for various biomedical applications as more realistic disease phenotypes can be created using fully human-origin platforms.

Entities:  

Keywords:  CRISPR/Cas9; disease modeling; iPSC

Mesh:

Substances:

Year:  2019        PMID: 30704346      PMCID: PMC6535964          DOI: 10.1089/ten.TEA.2018.0271

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  54 in total

1.  Culture of skin cells in 3D rather than 2D improves their ability to survive exposure to cytotoxic agents.

Authors:  Tao Sun; Simon Jackson; John W Haycock; Sheila MacNeil
Journal:  J Biotechnol       Date:  2006-01-30       Impact factor: 3.307

2.  Gelatin Methacrylate Hydrogels as Biomimetic Three-Dimensional Matrixes for Modeling Breast Cancer Invasion and Chemoresponse in Vitro.

Authors:  Anuradha D Arya; Pavan M Hallur; Abhijith G Karkisaval; Aditi Gudipati; Satheesh Rajendiran; Vaibhav Dhavale; Balaji Ramachandran; Aravindakshan Jayaprakash; Namrata Gundiah; Aditya Chaubey
Journal:  ACS Appl Mater Interfaces       Date:  2016-08-18       Impact factor: 9.229

3.  CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.

Authors:  Su Yang; Renbao Chang; Huiming Yang; Ting Zhao; Yan Hong; Ha Eun Kong; Xiaobo Sun; Zhaohui Qin; Peng Jin; Shihua Li; Xiao-Jiang Li
Journal:  J Clin Invest       Date:  2017-06-19       Impact factor: 14.808

Review 4.  Modeling Disease In Vivo With CRISPR/Cas9.

Authors:  Lukas E Dow
Journal:  Trends Mol Med       Date:  2015-10       Impact factor: 11.951

5.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.

Authors:  J A Forsythe; B H Jiang; N V Iyer; F Agani; S W Leung; R D Koos; G L Semenza
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

6.  Cell-laden microengineered gelatin methacrylate hydrogels.

Authors:  Jason W Nichol; Sandeep T Koshy; Hojae Bae; Chang M Hwang; Seda Yamanlar; Ali Khademhosseini
Journal:  Biomaterials       Date:  2010-04-24       Impact factor: 12.479

7.  Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

Authors:  C M Storgard; D G Stupack; A Jonczyk; S L Goodman; R I Fox; D A Cheresh
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

8.  Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1.

Authors:  Dominador J Manalo; Ashley Rowan; Tera Lavoie; Lakshmi Natarajan; Brian D Kelly; Shui Q Ye; Joe G N Garcia; Gregg L Semenza
Journal:  Blood       Date:  2004-09-16       Impact factor: 22.113

Review 9.  Hypoxia-inducible factors and the prevention of acute organ injury.

Authors:  Samuel N Heyman; Seymour Rosen; Christian Rosenberger
Journal:  Crit Care       Date:  2011-03-22       Impact factor: 9.097

10.  Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells.

Authors:  Christoph Patsch; Ludivine Challet-Meylan; Eva C Thoma; Eduard Urich; Tobias Heckel; John F O'Sullivan; Stephanie J Grainger; Friedrich G Kapp; Lin Sun; Klaus Christensen; Yulei Xia; Mary H C Florido; Wei He; Wei Pan; Michael Prummer; Curtis R Warren; Roland Jakob-Roetne; Ulrich Certa; Ravi Jagasia; Per-Ola Freskgård; Isaac Adatto; Dorothee Kling; Paul Huang; Leonard I Zon; Elliot L Chaikof; Robert E Gerszten; Martin Graf; Roberto Iacone; Chad A Cowan
Journal:  Nat Cell Biol       Date:  2015-07-27       Impact factor: 28.824

View more
  7 in total

Review 1.  CRISPR/Cas9 facilitates genomic editing for large-scale functional studies in pluripotent stem cell cultures.

Authors:  Xiao-Fei Li; Yong-Wei Zhou; Peng-Fei Cai; Wei-Cong Fu; Jin-Hua Wang; Jin-Yang Chen; Qi-Ning Yang
Journal:  Hum Genet       Date:  2019-10-12       Impact factor: 4.132

2.  Vascular Microphysiological Systems to Model Diseases.

Authors:  Qiao Zhang; Xu Zhang; George A Truskey
Journal:  Cell Gene Ther Insights       Date:  2020-02-14

Review 3.  Myocardial infarction from a tissue engineering and regenerative medicine point of view: A comprehensive review on models and treatments.

Authors:  Gozde Basara; Gokhan Bahcecioglu; S Gulberk Ozcebe; Bradley W Ellis; George Ronan; Pinar Zorlutuna
Journal:  Biophys Rev (Melville)       Date:  2022-08-30

Review 4.  Disease-inspired tissue engineering: Investigation of cardiovascular pathologies.

Authors:  LaTonya R Simon; Kristyn S Masters
Journal:  ACS Biomater Sci Eng       Date:  2019-10-29

Review 5.  Breast cancer models: Engineering the tumor microenvironment.

Authors:  Gokhan Bahcecioglu; Gozde Basara; Bradley W Ellis; Xiang Ren; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2020-02-09       Impact factor: 8.947

6.  Adipose stem cell secretome markedly improves rodent heart and human induced pluripotent stem cell-derived cardiomyocyte recovery from cardioplegic transport solution exposure.

Authors:  Bradley W Ellis; Dmitry O Traktuev; Stephanie Merfeld-Clauss; Uryan Isik Can; Meijing Wang; Ray Bergeron; Pinar Zorlutuna; Keith L March
Journal:  Stem Cells       Date:  2020-12-23       Impact factor: 6.277

Review 7.  A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing.

Authors:  Apresio K Fajrial; Qing Qing He; Nurul I Wirusanti; Jill E Slansky; Xiaoyun Ding
Journal:  Theranostics       Date:  2020-04-15       Impact factor: 11.556

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.